| The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan T Takahashi, K Maeda, T Suzuki, A Ishido, T Shigeoka, T Tominaga, ... The Journal of infectious diseases 209 (6), 816-827, 2014 | 769 | 2014 |
| Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) H Nishiura, H Oshitani, T Kobayashi, T Saito, T Sunagawa, T Matsui, ... MedRxiv, 2020.02. 28.20029272, 2020 | 354 | 2020 |
| Epidemiology of COVID-19 outbreak in Japan, January–March 2020 Y Furuse, YK Ko, M Saito, Y Shobugawa, K Jindai, T Saito, H Nishiura, ... Japanese journal of infectious diseases, JJID. 2020.271, 2020 | 95 | 2020 |
| Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8 T Saito, T Fujii, Y Kanatani, M Saijo, S Morikawa, H Yokote, T Takeuchi, ... Jama 301 (10), 1025-1033, 2009 | 73 | 2009 |
| MHLW COVID-19 Response Team; Suzuki, M. Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) H Nishiura, H Oshitani, T Kobayashi, T Saito, T Sunagawa, T Matsui, ... MedRxiv, 2020 | 67 | 2020 |
| Nudges for COVID-19 voluntary vaccination: How to explain peer information? S Sasaki, T Saito, F Ohtake Social science & medicine 292, 114561, 2022 | 58 | 2022 |
| A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion T Saito, M Nishi, MI Lim, B Wu, T Maeda, H Hashimoto, T Takeuchi, ... Journal of Biological Chemistry 283 (20), 14041-14052, 2008 | 58 | 2008 |
| Duration of infectious virus shedding by SARS-CoV-2 Omicron variant–infected vaccinees K Takahashi, M Ishikane, M Ujiie, N Iwamoto, N Okumura, T Sato, ... Emerging infectious diseases 28 (5), 998, 2022 | 57 | 2022 |
| Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8 A Eto, T Saito, H Yokote, I Kurane, Y Kanatani Vaccine 33 (45), 6106-6111, 2015 | 44 | 2015 |
| Pyruvate kinase type-II isozyme in Plasmodium falciparum localizes to the apicoplast T Maeda, T Saito, OS Harb, DS Roos, S Takeo, H Suzuki, T Tsuboi, ... Parasitology international 58 (1), 101-105, 2009 | 35 | 2009 |
| Characterisation of hexokinase in Toxoplasma gondii tachyzoites T Saito, T Maeda, M Nakazawa, T Takeuchi, T Nozaki, T Asai International journal for parasitology 32 (8), 961-967, 2002 | 31 | 2002 |
| Roles of public health centers and cluster-based approach for COVID-19 response in Japan T Imamura, T Saito, H Oshitani Health security 19 (2), 229-231, 2021 | 27 | 2021 |
| Expression and characterization of recombinant pyruvate kinase from Toxoplasma gondii tachyzoites T Maeda, T Saito, Y Oguchi, M Nakazawa, T Takeuchi, T Asai Parasitology research 89, 259-265, 2003 | 27 | 2003 |
| Serological responses in humans to the smallpox vaccine LC16m8 BF Johnson, Y Kanatani, T Fujii, T Saito, H Yokote, GL Smith The Journal of general virology 92 (Pt 10), 2405, 2011 | 26 | 2011 |
| Functioning of the International Health Regulations during the COVID-19 pandemic P Aavitsland, X Aguilera, SS Al-Abri, V Amani, CC Aramburu, TA Attia, ... The Lancet 398 (10308), 1283-1287, 2021 | 24 | 2021 |
| Severe fever with thrombocytopenia syndrome in Japan and public health communication T Saito, K Fukushima, K Umeki, K Nakajima Emerging Infectious Diseases 21 (3), 487, 2015 | 24 | 2015 |
| Simulated tabletop exercise for risk management-anti bio-terrorism scenario simulated tabletop exercise H Deguchi, T Saito, M Ichikawa, H Tanuma Developments in Business Simulation and Experiential Learning: Proceedings …, 2011 | 23 | 2011 |
| Genome recombination between Delta and Alpha variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T Sekizuka, K Itokawa, M Saito, M Shimatani, S Matsuyama, H Hasegawa, ... MedRxiv, 2021.10. 11.21264606, 2021 | 22 | 2021 |
| Mass casualty decontamination in a chemical or radiological/nuclear incident with external contamination: Guiding principles and research needs SM Cibulsky, D Sokolowski, M Lafontaine, C Gagnon, PG Blain, D Russell, ... PLoS currents 7, 2015 | 19 | 2015 |
| Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B. 1.1. 529 lineage) in international travelers to Japan T Maruki, N Iwamoto, K Kanda, N Okumura, G Yamada, M Ishikane, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 17* | 2022 |
